ShowcasesPricing
  1. US-listed companies
  2. Theravance Biopharma, Inc.

Theravance Biopharma, Inc.TBPH

Market cap
$447.45M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data